Prevention of Hypocalcemia in Patients Undergoing Total Thyroidectomy Plus Central Neck Dissection

This study has been completed.
Sponsor:
Collaborator:
Chungnam National University
Information provided by:
Asan Medical Center
ClinicalTrials.gov Identifier:
NCT00630214
First received: February 25, 2008
Last updated: March 5, 2008
Last verified: February 2008
  Purpose

the increased risk of hypocalcemia following total thyroidectomy plus central neck dissection can be minimized by routine administration of oral calcium and vitamin D supplements during the early postoperative period.


Condition Intervention Phase
Hypocalcemia
Dietary Supplement: Oral calcium plus vitamin D
Dietary Supplement: Oral calcium alone
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Phase 2 Study of Routine Oral Calcium and Vitamine D Supplements to Prevent Hypocalcemia After Total Thyroidectomy in Papillary Thyroid Carcinoma Patients

Resource links provided by NLM:


Further study details as provided by Asan Medical Center:

Primary Outcome Measures:
  • The clinical utility of calcium and vitamin D supplements for prevention of hypocalcemia following total thyroidectomy plus central neck dissection [ Time Frame: To postoperative 12 months ] [ Designated as safety issue: Yes ]

Enrollment: 200
Study Start Date: May 2004
Study Completion Date: February 2006
Primary Completion Date: February 2006 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: C
No supplements after total thyroidectomy and central neck dissection
No Intervention: D
No central neck dissection group (total thyroidectomy alone)
Active Comparator: A
Oral calcium plus vitamin D supplements after total thyroidectomy and central neck dissection
Dietary Supplement: Oral calcium plus vitamin D
calcium supplementation took 3 g/day oral calcium (1 g every 8 h) plus 1 mcg/day vitamin D (0.5 mcg every 12 h), beginning on the night of surgery and continuing for 14 days.
Other Name: calcium carbonate and one-alpha (vitamin D)
Active Comparator: B
Oral calcium alone supplement after total thyroidectomy and central neck dissection
Dietary Supplement: Oral calcium alone
calcium carbonate (3 g/day, 1 g every 8 h)
Other Name: calcium carbonate (Korea United Pharmaceutical Co, Seoul, Korea)

Detailed Description:

Of patients with differentiated papillary thyroid carcinoma, group D underwent total thyroidectomy alone and groups A-C underwent total thyroidectomy plus CND. The latter were randomized to oral calcium (3 g/day) plus vitamin D (1 mcg/day) (group A, n = 49), calcium alone (group B, n = 49), or no supplements (group C, n = 50). Hypocalcemic symptoms, serum calcium, and parathyroid hormone (PTH) levels were compared among the groups.

  Eligibility

Ages Eligible for Study:   15 Years to 85 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Differentiated papillary thyroid carcinoma
  • Undergoing total thyroidectomy plus central neck dissection

Exclusion Criteria:

  • Previous thyroid or neck surgery
  • Patients with parathyroid diseases
  • Other thyroid malignancies
  • Early loss of follow-up without proper evaluation of postoperative serum calcium levels and symptoms
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00630214

Locations
Korea, Republic of
Chungnam National University Hospital
Daejeon, Korea, Republic of, 301-040
Sponsors and Collaborators
Asan Medical Center
Chungnam National University
Investigators
Principal Investigator: Jong-Lyel Roh, MD, PhD Asan Medical Center & Chungnam National University Hospital
  More Information

Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Jong-Lyel Roh, MD, PhD, Chungnam National University Hospital & Asan Medical Center
ClinicalTrials.gov Identifier: NCT00630214     History of Changes
Other Study ID Numbers: 2004-03-01
Study First Received: February 25, 2008
Last Updated: March 5, 2008
Health Authority: South Korea: Institutional Review Board

Keywords provided by Asan Medical Center:
Total thyroidectomy
CND
hypocalcemia
calcium
vitamin D

Additional relevant MeSH terms:
Hypocalcemia
Calcium Metabolism Disorders
Metabolic Diseases
Water-Electrolyte Imbalance
Vitamins
Vitamin D
Ergocalciferols
Calcium, Dietary
Calcium Carbonate
Micronutrients
Growth Substances
Physiological Effects of Drugs
Pharmacologic Actions
Bone Density Conservation Agents
Antacids
Molecular Mechanisms of Pharmacological Action

ClinicalTrials.gov processed this record on October 01, 2014